Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

Officials estimated that 228 fewer babies younger than 3 months older were hospitalized for serious RSV infection during the peak of the season, a number they hope will increase as more women are ...

NYC Health said the Legionnaires' disease outbreak in Central Harlem is now up to 73 cases, including 3 deaths, an increase ...

HHS Secretary Robert F. Kennedy Jr. last month quietly endorsed recommendations from his handpicked vaccine advisors that ...

The CDC expanded RSV vaccine recommendations to include adults aged 50 and above who have underlying health conditions ...

Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, sparking concerns among medical experts.

The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates (newborns) and ...

The RSV recommendations were made by the CDC’s previous vaccine advisory panel, which Kennedy completely purged last month in a move that he claimed would help “reestablish public confidence in ...

The committee approved one dose of clesrovimab for infants not protected from respiratory syncytial virus (RSV) from their mothers, one of two monoclonal antibody products currently available.

The committee approved one dose of clesrovimab for infants not protected from respiratory syncytial virus (RSV) from their mothers, one of two monoclonal antibody products currently available.